Approval · Notice of Compliance 2272 · 2001
PMS-FLUOX: Notice of Compliance 2272
Issued April 26, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2272
- Date
- April 26, 2001
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New product name
- Therapeutic class
- Antidepressant, antiobsessional, antibulimic
- Canadian reference product
- PROZAC (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-FLUOX | 02243833 | Cancelled Pre Market |
Medicinal ingredients
- FLUOXETINE HYDROCHLORIDE 20 MG per CAP